Skip to main content

Advertisement

Log in

Growth and metastasis of human bladder cancer xenografts in the bladder of nude rats

A model for intravesical radioimmunotherapy

  • Original Articles
  • Published:
Urological Research Aims and scope Submit manuscript

Summary

A potentially useful therapeutic approach to the treatment of human bladder cancer is intravesical therapy with radiolabelled monoclonal antibodies (MAbs). We have established an animal model to study this approach. Inoculation of cloned 2B8 cells derived from the human bladder cancer cell line, UCRU-BL-17, into the bladder wall of nude rats pre-irradiated with 900 rads, resulted in local tumour growth in 39/40 (97.5%) animals, with invasion or metastases to distant organs in 25% of cases. Both the bladder tumours and the metastases were morphologically similar to the original biopsy sample from which the cell line, UCRU-BL-17, was established. The cells were of human origin, as shown by expression of HLA antigens, Alu probing, and cytogenetic analysis. Preliminary studies indicated that i.p. injection of anti-human bladder cancer monoclonal antibody (MAb), BLCA-38, radiolabelled with either iodine 131 or samarium 153 (153Sm), resulted in tumour localisation, with tumour-to-blood ratios of 5.04 (131I), and 4.3 and 3.1 (153Sm) respectively. We now aim to examine the efficacy of the intravesical route for radioimmunotherapy in the nude rat model. This model will also serve for preclinical studies on the efficacy of systemically injected radioimmunoconjugates for control of metastatic growth.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ahlering TE, Dubeau L, Jones P (1987) A new in vivo model to study invasion and metastais of human bladder cancer. Cancer Res 47:6660

    Google Scholar 

  2. Bander NH (1986) Monoclonal antibodies in urologic oncology. Cancer 60:658

    Google Scholar 

  3. Boniface GR, Izard ME, Walker WZ, McKay DR, Sorby PJ, Turner JH, Morris JG (1989) Labeling of monoclonal antibodies with Samarium-153 for combined radioimmunoscintigraphy and radioimmunotherapy. J Nucl Med 30:683

    Google Scholar 

  4. Brechbiel MW, Gansow OA, Atcher RW, Schlom J, Esteban J, Simpson DE, Colcher D (1986) Synthesis 1-(p-isothiocyanatobenzyl) derivative of DTPA and EDTA. Antibody labeling and tumor-imaging studies. Inorg Chem 25:2772

    Google Scholar 

  5. Brown J, Russell PJ, Philips J, Wotherspoon J, Raghavan D (1990) Clonal analysis of a bladder cancer cell line: an experimental model of tumour heterogeneity. Br J Cancer 61:369

    Google Scholar 

  6. Chen TR (1977) In situ detection of Mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp Cel Res 104:255

    Google Scholar 

  7. Colcher D, Esteban J, Carrasquillo JA, Sugarbaker P, Reynolds JC, Bryant G, Larson SM, Schlom J (1987) Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma. Cancer Res 47:4218

    Google Scholar 

  8. Drago JR (1984) The nobel rat bladder cancer model: FANFT-induced tumors. Cancer Res 53:1093

    Google Scholar 

  9. Ehrhardt GT, Ketring AR, Volkert WA (1986) Production of SM-153 for radiotherapeutic applications. J Labeled Comp 23:1370

    Google Scholar 

  10. Epenetos AA (1989) Radiolabeled monoclonal antibodies for therapy of ovarian cancer. Nucl Med Biol 16:182

    Google Scholar 

  11. Fidler IJ (1986) Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis. Cancer and Metastasis Reviews 5:29

    Google Scholar 

  12. Goldenberg DM, Pavia RA (1982) In vivo horizontal oncogenesis by a human tumour in nmude mice. Proc Nat Acad Sci USA 79:2389

    Google Scholar 

  13. Hoogenhout J, Bakkeren JAJ, Van Gasteren JJM, Jerusalem CR, Kal HB, Kazem I (1987) Development and applications of an animal model for human tumour xenografts. In vivo 1:69

    Google Scholar 

  14. ISCN (1978) An international system for human cytogenetic nomenclature. Cytogenet Cell Genet 21:309

    Google Scholar 

  15. Kovnat A, Buick RN, Connolly JG, Jewett MA, Keresteci AG, Tannock I (1984) Comparison of growth of human bladder cancer in tissue culture or as xenografts with clinical and pathological characteristics. Cancer Res 44:2530

    Google Scholar 

  16. Kozak RW, Raubitschek A, Mirzadeh S, Brechbiel MW, Junghaus R, Gansow OA, Waldmann TA (1989) Nature of the bifunctional chelating agent usef for radioimmunotherapy with Ytrrium-90 monoclonal antibodies: critical factors in determining in vivo survival and organ toxicity. Cancer Res 49:2639

    Google Scholar 

  17. Kyriazis AP, Yagoda A, Keriakes JG, Kyriazis AA, Whitmore JG Jr (1983) Experimental studies on the radiation-modifying effect of cisdiamminedichloroplatinum II (DDP) in human bladder transitional cell carcinomas growth in nude mice. Cancer 52:452

    Google Scholar 

  18. Lightfoot DV, Walker KZ, Boniface GR, Hetherington EL, Izard M, Russell PJ (1991) Dosimetric and therapeutic studies in nude mouse xenograft models with 153Samarium-labeled BLCA-38 antibody. Antibody Immunoconjugates & Radiopharmaceuticals (in press)

  19. McCabe RP, Haspel MV, Pomato N, Hanna MG (1988) Monoclonal antibodies in the detection of bladder cancer. In: Pugchik HZ (ed) Cancer diagnosis in vitro using monoclonal antibodies. Dekker, New York Basel, p 1

    Google Scholar 

  20. Morikawa K, Walker SM, Nakajima M, Pathak S, Jessup JM and Fidler IJ (1988) Influence of organ environment on the growth, selection and metastasis of human colon carcinoma cells in nude mice. Cancer Res 48:6863

    Google Scholar 

  21. Naito S, von Eschenbach AC, Fidler IJ (1987) Different growth pattern and biologic behavior of human renal cell carcinoma implanted into different organs of nude mice. JNCI 78:377

    Google Scholar 

  22. Paget S (1889) The distribution of secondary growth in cancer of the breast. Lancet I:571

    Google Scholar 

  23. Raghavan D, Shipley WU, Garnick MB, Russell PJ, Richie JP (1990) Biology and management of bladder cancer. N Engl J Med 322:1129

    Google Scholar 

  24. Riva, Marangolo M, Lazzari S, Agostini M, Sarti G, Moscatelli G, Franceschi G, Spinelli A, Vecchietti G (1989) Locoregional immunotherapy of human ovarian cancer: preliminary results. Nucl Med Biol 16:659

    Google Scholar 

  25. Russell PJ, Raghavan D, Gregory P, Philips J, Wills EJ, Jelbart M, Wass J, Zbroja RA, Vincent PC (1986) Bladder cancer xenografts: a model of tumour cell heterogeneity. Cancer Res 46:2035

    Google Scholar 

  26. Russell PJ, Jelbart M, Wills E, Singh S, Wass J, Wotherspoon J, Raghavan D (1988) Establishment and characterization of a new human bladder cancer cell line showing features of squamous and glandular differentiation. Int J Cancer 41:74

    Google Scholar 

  27. Russell PJ, Wills EJ, Philips J, Wass J, Jelbart M, Gregory P, Raghavan D (1988) Features of squamous and adenocarcinoma in the same cell in a xenograft human transitional cell carcinoma: Evidence of a common histogenesis? Urol Res 16:79

    Google Scholar 

  28. Russell PJ, Wass J, Garson OM, Jelbart M, Wills EJ, Philips J, Brown J, Carrington N, Vincent PC, Raghavan D (1989) Characterisation of cell lines derived from a human bladder transitional cell carcinoma, UCRU-BL-13, showing muliple aneuploidy. Int J Cancer 44:276

    Google Scholar 

  29. Russell PJ, Boniface GR, Izard ME, Lightfoot DV, Gansow O, Brechbiel M, Raghavan D, Walker KZ (1990) Development of animal models to assess radioimmunoconjugates for the treatment of baldder cancer Proceedings of Conference on Treatment of Melanoma and Other Cancers, Sept. 1990, Newcastle, NSW

  30. Russell PJ, Brown J, Grimmond S, Stapleton P, Russell P, Raghavan D, Symonds G (1990) Tumour-induced host stromal-cell transformation: induction of mouse spindle-cell fibrosarcoma not mediated by gene transfer. Int J Cancer 46:299

    Google Scholar 

  31. Seabright M (1971) A rapid banding technique for human chromosomes. Lancet II:971

    Google Scholar 

  32. Steinberg GD, Brendler CB, Ichikawa T, Squire RA, Isaacs JT (1990) Characterization of an N-methyl-N-nitrosourea (MNU) induced autochothonous rat bladder cancer model. Cancer Res 50:6668

    Google Scholar 

  33. Tannock IF, Choo B, Buick R (1984) The radiation response of human bladder cancer assessed in vitro or as xenografts in immune-deprived mice. Int J Radiat Oncol Biol Phys 10:1897

    Google Scholar 

  34. Walker KZ (1988) Clinical applications of monoclonal antibodies. Modern Medicine of Australia, April, 106

  35. Walker KZ, Seymour-Munn K, Keech FK, Axiak SM, Bautovich GJ, Morris JG, Basten A (1986) A rat model system for radioimmunodetection of kappa myeloma antigen on malignant B cells. Eur J Nucl Med 12:461

    Google Scholar 

  36. Walker KZ, Russell PJ, Kingsley EA, Philips J, Raghavan D (1989) Detection of malignant cells in voided urine in patients with bladder cancer, a novel monoclonal assay. J Urol 142:1578

    Google Scholar 

  37. Wang CY, Zukowski K, Yamada H, Imaida K, Lee M-S (1990) Production of urothelial tumors in the heterotopic bladder of rats by benzidine derivatives. Cancer Res 50:2868

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by grants from the University of Sydney Cancer Research Fund and the Australian Kidney Foundation

Rights and permissions

Reprints and permissions

About this article

Cite this article

Russell, P.J., Shon, I.H., Boniface, G.R. et al. Growth and metastasis of human bladder cancer xenografts in the bladder of nude rats. Urol. Res. 19, 207–213 (1991). https://doi.org/10.1007/BF00305296

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00305296

Key words

Navigation